Clinical Trials Browser

Phase 3 × Completed × HER2-positive Breast Cancer × Clear all

NCT03588091 2025-08-22

Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer

Phase 3 Completed

HER2-positive Breast Cancer

NCT06107790 2023-10-30

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer

Phase 3 Completed

HER2-positive Breast Cancer